Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03248869 · ClinicalTrials.gov registry record · NA
Asthma Mobile Health Application 2.0
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 7,752
- Enrollment target
NCT03248869 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 7,752 participants.
The verdict
NCT03248869, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,752 participants
- Enrollment target
Study Summary
Mobile health applications (MHA) are increasingly being explored as tools to assist in management of chronic diseases. Little is known regarding which characteristics of MHAs are effective and there is limited data suggesting a real-world impact on health outcomes. Asthma is one of the most common and costly of the chronic diseases, impacting a broad range of the population including both children and adults. It is a variable disease necessitating regular medication use, monitoring of symptoms, and avoidance of specific triggers. These characteristics of asthma make it a chronic disease that is particularly amenable to having an MHA facilitate active monitoring outside of periodic traditional medical visits. The study team has designed a MHA focused on asthma subjects to test the feasibility of an asthma mobile health application (AMHA). The AMHA 2.0 study is the result of a collaboration between MHA developers and Mount Sinai faculty with expertise in the fields of asthma, research design, data storage, and data analysis. AMHA 2.0 incorporated elements of usual clinical care (that may take place during typical office visits), such as medication reminders, a daily asthma diary to track asthma control (AC) and medication use, patient education and assessments of quality of life (QoL), and health care utilization (HCU).
Interventions
- OTHER Mobile Health App
- OTHER Current Daily Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,752 participants |
| Start Date | 2015-03-15 |
| Est. Completion | 2017-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03248869
The ClinicalTrials.gov registry entry for NCT03248869 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,752 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mobile Health App is the first listed.
NCT03248869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03248869 about?
NCT03248869 is a clinical study titled "Asthma Mobile Health Application 2.0". Mobile health applications (MHA) are increasingly being explored as tools to assist in management of chronic diseases. Little is known regarding which characteristics of MHAs are effective and there is limited data suggesting a real-world impact on health outcomes. Asthma is one of the most common a...
What is the current status of trial NCT03248869?
This trial is currently completed. It is a NA study. The enrollment target is 7,752 participants. The study started on 2015-03-15. Estimated completion is 2017-03-15.
What interventions are being tested in trial NCT03248869?
The interventions under investigation include: Mobile Health App (OTHER), Current Daily Survey (OTHER).
Who is sponsoring clinical trial NCT03248869?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.